Bovie Medical (BVX) Misses Q2 EPS by 1c

Bovie Medical (NYSE: BVX) reported Q2 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $9 million.

GUIDANCE:

Bovie Medical sees Q3 2017 revenue of $38.3-40.3 million.

For earnings history and earnings-related data on Bovie Medical (BVX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Dollar General (DG) Tops Q2 EPS by 48c, Beats on Revenue; Offers FY27 EPS Guidance
• Chagee Holdings (CHA) Tops Q2 EPS by 3c